Managing Blood Cancer Patients' Oral Complications: Preventive Strategies during and after Treatment

Blood cancers, encompassing leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN), bring complex challenges to patient management due to their impact on hematopoiesis, immunity, and overall health. This review focuses on equipping dental practitioners with essential insights into preventing and managing intricate oral manifestations during and after treatment. Patient care strategies are outlined for leukemia subtypes such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML), emphasizing the need for tailored dental approaches. In lymphomas encompassing Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), distinct oral implications warrant individualized attention in patient management. The review delves into preventive strategies for oral complications stemming from myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms, underlining the importance of anticipatory care. Comprehensive treatment modalities, including chemotherapy, immunotherapy, radiation, and stem cell transplantation, provoke oral repercussions, necessitating proactive measures for symptom management and patient comfort. The role of dental practitioners in coordinating care with oncologists is underscored, emphasizing early oral evaluations, treatment planning, and ongoing support to mitigate complications. In navigating the oral complexities of blood cancers, this review empowers dental practitioners to prioritize patient well-being through informed preventive strategies and multidisciplinary collaboration.